Wang Zhanggui, Han Weidong, Sui Xinbing, Fang Yong, Pan Hongming
Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang 310016, P.R. China.
Oncol Lett. 2014 May;7(5):1345-1351. doi: 10.3892/ol.2014.1916. Epub 2014 Feb 26.
Autophagy is a highly conserved intracellular degradation process and plays an important role in hepatocarcinogenesis. Available data show that autophagy is involved in anti-hepatocarcinoma (HCC) therapies. Autophagy regulation involves a novel target for overcoming therapeutic resistance and sensitizing HCC to currently therapeutic methods. This is a systematic review on the interface of autophagy and the development of HCC and outlining the role of autophagy in current anti-HCC approaches. Understanding the significance of autophagy in anti-HCC therapy may offer a novel therapeutic target for improving anti-cancer efficacy and prolong survival for HCC patients.
自噬是一种高度保守的细胞内降解过程,在肝癌发生过程中起重要作用。现有数据表明自噬参与了抗肝癌(HCC)治疗。自噬调节涉及克服治疗耐药性以及使肝癌对当前治疗方法敏感化的新靶点。这是一篇关于自噬与肝癌发生之间关系的系统综述,并概述了自噬在当前抗肝癌方法中的作用。了解自噬在抗肝癌治疗中的意义可能为提高抗癌疗效和延长肝癌患者生存期提供新的治疗靶点。